BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9637625)

  • 1. Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases.
    Sawin PD; Hitchon PW; Follett KA; Torner JC
    Surg Neurol; 1998 Jun; 49(6):640-9. PubMed ID: 9637625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases.
    McGirt MJ; Woodworth GF; Coon AL; Frazier JM; Amundson E; Garonzik I; Olivi A; Weingart JD
    J Neurosurg; 2005 May; 102(5):897-901. PubMed ID: 15926716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique.
    Woodworth GF; McGirt MJ; Samdani A; Garonzik I; Olivi A; Weingart JD
    J Neurosurg; 2006 Feb; 104(2):233-7. PubMed ID: 16509497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and diagnostic value of frame-based and CT-guided stereotactic brain biopsy technique.
    Ersahin M; Karaaslan N; Gurbuz MS; Hakan T; Berkman MZ; Ekinci O; Denizli N; Aker FV
    Turk Neurosurg; 2011; 21(4):582-90. PubMed ID: 22194120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic biopsies of focal brainstem lesions.
    Gonçalves-Ferreira AJ; Herculano-Carvalho M; Pimentel J
    Surg Neurol; 2003 Oct; 60(4):311-20; discussion 320. PubMed ID: 14505847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions.
    Bernstein M; Parrent AG
    J Neurosurg; 1994 Aug; 81(2):165-8. PubMed ID: 8027795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell's system.
    Yamada K; Goto S; Kochi M; Ushio Y
    J Clin Neurosci; 2004 Apr; 11(3):263-7. PubMed ID: 14975414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and diagnostic yield of stereotactic biopsy for the patients with malignant brain tumors].
    Takahashi H; Sugai T; Uzuka T; Kano M; Honma J; Grinev I; Tanaka R
    No Shinkei Geka; 2004 Feb; 32(2):135-40. PubMed ID: 15031974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of frameless and frame-based intracranial biopsy techniques.
    Dammers R; Haitsma IK; Schouten JW; Kros JM; Avezaat CJ; Vincent AJ
    Acta Neurochir (Wien); 2008 Jan; 150(1):23-9. PubMed ID: 18172567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frameless stereotaxy with scalp-applied fiducial markers for brain biopsy procedures: experience in 218 cases.
    Barnett GH; Miller DW; Weisenberger J
    J Neurosurg; 1999 Oct; 91(4):569-76. PubMed ID: 10507376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity of stereotactic biopsy for intracranial lesions.
    Nishihara M; Sasayama T; Kudo H; Kohmura E
    Kobe J Med Sci; 2011 Jan; 56(4):E148-53. PubMed ID: 21937861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies.
    Grossman R; Sadetzki S; Spiegelmann R; Ram Z
    Acta Neurochir (Wien); 2005 Jun; 147(6):627-31; discussion 631. PubMed ID: 15821863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of stereotactic biopsy for intracranial lesions.
    Hall WA
    Cancer; 1998 May; 82(9):1749-55. PubMed ID: 9576298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy.
    Field M; Witham TF; Flickinger JC; Kondziolka D; Lunsford LD
    J Neurosurg; 2001 Apr; 94(4):545-51. PubMed ID: 11302651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance.
    Shakal AA; Mokbel EA
    J Neurol Surg A Cent Eur Neurosurg; 2014 May; 75(3):177-82. PubMed ID: 23526202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging.
    Bernays RL; Kollias SS; Khan N; Brandner S; Meier S; Yonekawa Y
    J Neurosurg; 2002 Aug; 97(2):354-62. PubMed ID: 12186464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized tomography-guided stereotactic surgery for brainstem masses: a risk-benefit analysis in 71 patients.
    Rajshekhar V; Chandy MJ
    J Neurosurg; 1995 Jun; 82(6):976-81. PubMed ID: 7760201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative assessment of haemostasis in patients undergoing stereotactic brain biopsy.
    Beynon C; Wei S; Radbruch A; Capper D; Unterberg AW; Kiening KL
    J Clin Neurosci; 2018 Jul; 53():112-116. PubMed ID: 29685415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment.
    Kim JE; Kim DG; Paek SH; Jung HW
    Acta Neurochir (Wien); 2003 Jul; 145(7):547-54; discussion 554-5. PubMed ID: 12910397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic biopsy in the era of advanced neuroimaging. Does the minimal therapeutic gain justify its current wide use?
    Stranjalis G; Protopapa D; Sakas DE; Chondros D
    Minim Invasive Neurosurg; 2003 Apr; 46(2):90-3. PubMed ID: 12761679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.